Dr. Oliver Phan, MD

NPI: 1942463229
Total Payments
$1,078
2024 Payments
$28.50
Companies
25
Transactions
58
Medicare Patients
1,323
Medicare Billing
$263,871

Payment Breakdown by Category

Food & Beverage$952.52 (88.4%)
Education$125.14 (11.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $952.52 55 88.4%
Education $125.14 3 11.6%

Top Paying Companies

Company Total Records Latest Year
Otsuka America Pharmaceutical, Inc. $218.51 10 $0 (2020)
Otsuka Pharmaceutical Development & Commercialization, Inc. $122.20 1 $0 (2017)
OPKO Pharmaceuticals, LLC $78.91 6 $0 (2020)
Travere Therapeutics, Inc. $56.79 4 $0 (2024)
AstraZeneca Pharmaceuticals LP $56.14 4 $0 (2020)
Keryx Biopharmaceuticals, Inc. $54.70 3 $0 (2018)
GENZYME CORPORATION $52.58 4 $0 (2019)
Mallinckrodt Enterprises LLC $37.77 2 $0 (2019)
Astellas Pharma US Inc $34.26 2 $0 (2020)
Melinta Therapeutics, Inc. $34.18 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $28.50 2 Travere Therapeutics, Inc. ($28.50)
2020 $159.91 10 Otsuka America Pharmaceutical, Inc. ($31.67)
2019 $420.88 22 Otsuka America Pharmaceutical, Inc. ($150.27)
2018 $204.82 13 Keryx Biopharmaceuticals, Inc. ($38.57)
2017 $263.55 11 Otsuka Pharmaceutical Development & Commercialization, Inc. ($122.20)

All Payment Transactions

58 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
06/04/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $23.41 General
06/04/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $5.09 General
03/11/2020 TETRAPHASE PHARMACEUTICALS, INC. XERAVA (Drug) Food and Beverage In-kind items and services $25.00 General
Category: TETRACYCLINE CLASS ANTIBACTERIAL
03/03/2020 Travere Therapeutics, Inc. (815) Thiola (Drug) Food and Beverage In-kind items and services $11.75 General
Category: Kidney Stones
02/27/2020 Astellas Pharma US Inc CRESEMBA (Drug), AMBISOME, MYCAMINE Food and Beverage In-kind items and services $16.04 General
Category: HOSPITAL AND TRANSPLANT
02/14/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $14.62 General
Category: NEPHROLOGY
02/13/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $11.14 General
Category: Cardiovascular and Metabolism
01/15/2020 Amgen Inc. Parsabiv (Drug) Food and Beverage In-kind items and services $17.79 General
Category: Nephrology
01/15/2020 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Food and Beverage In-kind items and services $11.62 General
Category: Hyperparathyroidism
01/10/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $17.05 General
Category: NEPHROLOGY
01/09/2020 Travere Therapeutics, Inc. (815) Thiola (Drug) Food and Beverage In-kind items and services $16.54 General
Category: Kidney Stones
01/07/2020 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $18.36 General
Category: ANTIBIOTIC
12/13/2019 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Education In-kind items and services $61.20 General
Category: NEPHROLOGY
12/13/2019 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Education In-kind items and services $61.20 General
Category: NEPHROLOGY
12/03/2019 Mayne Pharma Inc. DORYX (Drug) Food and Beverage In-kind items and services $17.81 General
Category: DERMATOLOGY
11/26/2019 Astellas Pharma US Inc CRESEMBA (Drug), MYCAMINE, AMBISOME Food and Beverage In-kind items and services $18.22 General
Category: INFECTIOUS DISEASES
11/22/2019 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Drug) Food and Beverage In-kind items and services $20.76 General
Category: Immunology
11/13/2019 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $18.31 General
Category: NEUROLOGY
09/19/2019 Mayne Pharma Inc. DORYX (Drug) Food and Beverage In-kind items and services $14.29 General
Category: DERMATOLOGY
09/04/2019 Shire North American Group Inc NATPARA (PARATHYROID HORMONE) (Drug) Food and Beverage In-kind items and services $14.78 General
Category: INTERNAL MEDICINE
08/21/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $14.11 General
Category: Cardiovascular and Metabolism
08/15/2019 Retrophin, Inc. (815) Thiola (Drug) Food and Beverage In-kind items and services $15.11 General
Category: Kidney Stones
07/18/2019 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage Cash or cash equivalent $20.50 General
Category: NEPHROLOGY
06/06/2019 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $11.15 General
Category: Hyperparathyroidism
05/01/2019 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $12.43 General
Category: Hyperparathyroidism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 189 315 $90,374 $19,731
2022 11 300 594 $224,493 $67,866
2021 13 412 1,170 $314,140 $97,659
2020 12 422 1,484 $241,524 $78,615
Total Patients
1,323
Total Services
3,563
Medicare Billing
$263,871
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 68 166 $41,542 $9,689 23.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 42 43 $20,225 $4,091 20.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 25 35 $12,250 $2,297 18.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 24 30 $7,500 $1,637 21.8%
90935 Hemodialysis procedure with physician evaluation Facility 2023 18 29 $7,303 $1,569 21.5%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 12 12 $1,554 $449.76 28.9%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 20 91 $63,245 $25,391 40.1%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 17 42 $24,486 $9,843 40.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 43 102 $35,470 $7,971 22.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 65 140 $33,866 $7,541 22.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 26 27 $18,249 $3,972 21.8%
90935 Hemodialysis procedure with physician evaluation Facility 2022 33 67 $16,595 $3,783 22.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 20 25 $8,750 $2,971 34.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 32 $8,000 $2,751 34.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 20 20 $9,062 $1,849 20.4%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 20 35 $4,495 $996.04 22.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 11 13 $2,275 $798.43 35.1%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 25 109 $74,180 $30,580 41.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 100 237 $82,355 $19,052 23.1%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 21 52 $29,425 $11,998 40.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 45 45 $30,397 $7,009 23.1%
90962 Dialysis services (1 physician visit per month), patient 20 years of age and older Office 2021 15 42 $18,552 $6,778 36.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 68 90 $21,990 $5,031 22.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 45 52 $13,000 $4,679 36.0%
90970 Dialysis services, per day (less than full month service), patient 20 years of age or older Office 2021 14 449 $11,674 $3,431 29.4%

About Dr. Oliver Phan, MD

Dr. Oliver Phan, MD is a Nephrology healthcare provider based in Edina, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942463229.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Oliver Phan, MD has received a total of $1,078 in payments from pharmaceutical and medical device companies, with $28.50 received in 2024. These payments were reported across 58 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($952.52).

As a Medicare-enrolled provider, Phan has provided services to 1,323 Medicare beneficiaries, totaling 3,563 services with total Medicare billing of $263,871. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Edina, MN
  • Active Since 07/07/2008
  • Last Updated 01/20/2016
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1942463229

Products in Payments

  • SAMSCA (Drug) $158.97
  • TOLVAPTAN (Drug) $122.20
  • Rayaldee (Drug) $67.29
  • JYNARQUE (Drug) $59.54
  • LOKELMA (Drug) $56.14
  • Auryxia (Drug) $54.70
  • (815) Thiola (Drug) $43.40
  • FABRY-DISEASE (Drug) $39.35
  • ACTHAR (Biological) $37.77
  • CRESEMBA (Drug) $34.26
  • Baxdela (Drug) $34.18
  • DORYX (Drug) $32.10
  • XERAVA (Drug) $25.00
  • Rituxan (Biological) $24.34
  • Renal - PD (Device) $24.17
  • OCTAPLAS (Biological) $21.51
  • ULTOMIRIS (Drug) $20.76
  • AURYXIA (Drug) $20.50
  • NUZYRA (Drug) $18.36
  • NORTHERA (Drug) $18.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Edina